Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to compare the efficacy of escitalopram with that of
duloxetine in outpatients with Major Depressive Disorder (MDD) after 24 weeks of treatment.
The study hypothesis was that there were clinically important differences between the two
drugs in terms of efficacy and adverse event profiles.